Juvenile Idiopathic Arthritis

A validated prognostic tool using common clinical markers could help clinicians evaluate patients with juvenile idiopathic arthritis for chronic uveitis risk, according to data published in Arthritis & Rheumatology.

It is crucial that patients with juvenile arthritis stay active throughout their childhood for a better chance at building stronger bones, according to DMOS Orthopaedic Centers.

Higher health-related quality of life scores in children with juvenile idiopathic arthritis correspond to higher career- and health-related quality of life scores for their caregivers, according to data published in Pediatric Rheumatology.

ORLANDO — As many as one-half of children with juvenile idiopathic arthritis enter adult care with increased disease activity, according to a speaker at the 2022 Rheumatology Nurses Society Conference.

More than 75% of patients with juvenile idiopathic arthritis experience pain that has interfered with their ability to sleep, pay attention and run or walk short distances, according to an Arthritis Foundation report.

Children with juvenile idiopathic arthritis who require TNF inhibitors often experience insurance-led delays to therapy initiation, according to a research letter published in JAMA Network Open.

Adolescents experience longer wait times to see a pediatric rheumatologist for juvenile idiopathic arthritis, compared with younger children, according to research published in the Journal of Rheumatology.

Children and adolescents with rheumatic and musculoskeletal diseases who contract COVID-19 are not likely to require hospitalization, according to data published in the Annals of the Rheumatic Diseases.

Messenger RNA COVID-19 vaccines provide immunity through at least 6 months, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.

The American College of Rheumatology has released two updated guideline papers for the treatment and management of juvenile idiopathic arthritis, according to a press release.